Plasma fibrinogen, global cognitive function, and cerebral small vessel disease: Results of a cross-sectional study in community-dwelling Japanese elderly

Internal Medicine

Volumn 50, Issue 9, 2011, Pages 999-1007

  Wada, Manabu ^a   Takahashi, Yoshimi ^a   Iseki, Chifumi ^a   Kawanami, Toru ^a   Daimon, Makoto ^a   Kato, Takeo ^a,b  

^a YAMAGATA UNIVERSITY   (Japan)

^b YAMAGATA UNIVERSITY   (Japan)

Author keywords

Cognitive function; Community based study; Endothelial dysfunction; Fibrinogen; Magnetic resonance imaging; Small vessel disease

Indexed keywords

C REACTIVE PROTEIN; FIBRINOGEN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; THROMBOMODULIN; VON WILLEBRAND FACTOR CLEAVING PROTEINASE;

ADULT; AGE; AGED; ARTERY INTIMA PROLIFERATION; ARTICLE; BRAIN VENTRICLE; CEREBRAL SMALL VESSEL DISEASE; CEREBROVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; COGNITION; COMMUNITY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; FIBRINOGEN BLOOD LEVEL; GENDER; HUMAN; JAPANESE; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PREVALENCE; PROTEIN BLOOD LEVEL; SMOKING; SYSTOLIC BLOOD PRESSURE; WHITE MATTER; WHITE MATTER LESION;

AGED; ASIAN CONTINENTAL ANCESTRY GROUP; CEREBROVASCULAR DISORDERS; COGNITION; CROSS-SECTIONAL STUDIES; FEMALE; FIBRINOGEN; HUMANS; JAPAN; LEUKOENCEPHALOPATHIES; MAGNETIC RESONANCE IMAGING; MALE; MENTAL STATUS SCHEDULE; MIDDLE AGED; RESIDENCE CHARACTERISTICS; THROMBOMODULIN; VON WILLEBRAND FACTOR;

EID: 79955620153     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.50.4752     Document Type: Article

References (27)

1. Vermeer SE, Hollander M, van Dijk EL, Hofman A, Koudstaal PJ, Breteler MM. Silent brain infarcts and white matter lesions increase stroke risk in the general population: The Rotterdam Scan Study. Stroke 34: 1126-1129, 2003.
2. Vermeer SE, Prins ND, den Heijer T, Hofman A, Koudstaal PJ, Breteler MM. Silent brain infarcts and the risk of dementia and cognitive decline. N Engl J Med 348: 1215-1222, 2003.
3. Markus HS, Hunt B, Palmer K, Enzinger C, Schmidt H, Schmidt R. Markers of endothelial and hemostatic activation and progression of cerebral white matter hyperintensities: Longitudinal results of the Austrian Stroke Prevention Study. Stroke 36: 1410-1414, 2005.
4. Ernst E, Resch KL. Fibrinogen as a cardiovascular risk factor: A meta-analysis and review of the literature. Ann Intern Med 118: 956-963, 1993.
5. Danesh J, Lewington S, Thompson SG, et al. Plasma fibrinogen level and the risk of major cardiovascular disease and nonvascular mortality: An individual participant meta-analysis. JAMA 294: 1799-1809, 2005.
6. van Oijen M, Witteman JC, Hofman A, Koudstaal PJ, Breteler MM. Fibrinogen is associated with an increased risk of Alzheimer disease and vascular dementia. Stroke 36: 2637-2641, 2005.
7. Marioni RE, Stewart MC, Murray GD, et al. Peripheral levels of fibrinogen, C-reactive protein, and plasma viscosity predict future cognitive decline in individuals without dementia. Psychosom Med 71: 901-906, 2009.
8. Rafnsson S, Deary IJ, Whiteman MC, Rumley A, Lowe GD, Fowkes FG. Haemorheological predictors of cognitive decline: the Edinburgh Artery Study. Age Aging 39: 217-222, 2010.
9. Schmidt R, Fazekas F, Hayn M, et al. Risk factors for microangiopathy-related cerebral damage in the Austrian stroke prevention study. J Neurol Sci 152: 15-21, 1997.
10. Longstreth WT Jr, Manolio TA, Arnold A, et al. Clinical correlates of white matter findings on cranial magnetic resonance imaging of 3301 elderly people: The Cardiovascular Health Study. Stroke 27: 1274-1282, 1996.
11. Sato S, Nakamura M, Iida M, et al. Plasma fibrinogen and coronary heart disease in urban Japanese. Am J Epidemiol 152: 420-423, 2000.
12. Wada M, Nagasawa H, Kawanami T, et al. Cystatin C as an index of cerebral small vessel disease: Results of a cross-sectional study in community-based Japanese elderly. Eur J Neurol 17: 383-390, 2010.
13. Wada M, Nagasawa H, Kurita K, et al. Cerebral small vessel disease and C-reactive protein: Results of a cross-sectional study in community-based Japanese elderly. J Neurol Sci 264: 43-49, 2008.
14. Alberti KG, Zimmet PZ. Definition, diagnosis, and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO consultation. Diabet Med 15: 539-553, 1998.
15. Fazekas F, Kleinert R, Offenbacher H, et al. Pathologic correlates of incidental MRI white matter signal hyperintensities. Neurology 43: 1683-1689, 1993.
16. Wada M, Nagasawa H, Kurita K, et al. Microalbuminuria is a risk factor for cerebral small vessel disease in community-based elderly subjects. J Neurol Sci 255: 27-34, 2007.
17. Schmidt R, Fazekas F, Kapeller P, Schmidt H, Hartung HP. MRI white matter hyperintensities: Three-year follow-up of the Austrian Stroke Prevention Study. Neurology 53: 132-139, 1999.
18. Wardlaw JM, Sandercock PA, Dennis MS, Starr J. Is breakdown of the blood-brain barrier responsible for lacunar stroke, leukoaraiosis, and dementia? Stroke 34: 806-812, 2003.
19. Varga-Szabo D, Pleines I, Nieswandt B. Cell adhesion mechanisms in platelets. Arterioscler Thromb Vasc Biol 28: 403-412, 2008.
20. Adams RA, Passino M, Sachs BD, Nuriel T, Akassoglou K. Fibrin mechanisms and functions in nervous system pathology. Mol Interv 4: 163-176, 2004.
21. 2/Mac-1 is critical for host inflammatory response in vivo. J Clin Invest 113: 1596-1606, 2004.
22. Paul J, Strickland S, Melchor JP. Fibrin deposition accelerates neurovascular damage and neuroinflammation in mouse model of Alzheimer's disease. J Exp Med 204: 1999-2008, 2007.
23. Bowman GL, Kaya JA, Moore M, Waichunas D, Carlson NE, Quinn JF. Blood-brain barrier impairment in Alzheimer disease: Stability and functional significance. Neurology 68: 1809-1814, 2007.
24. Aono Y, Ohkubo T, Kikuya M, et al. Plasma fibrinogen, ambulatory blood pressure, and silent cerebrovascular lesions: The Ohasama Study. Arterioscler Thromb Vasc Biol 27: 963-968, 2007.
25. van Oijen M, Cheung EY, Geluk CE, et al. Haplotypes of the fibrinogen gene and cerebral small vessel disease: The Rotterdam scan study. J Neurol Neurosurg Psychiatry 79: 799-803, 2008.
26. Matsushita T, Kubo M, Yonemoto K, et al. Lack of association between variations of PDE4D and ischemic stroke in the Japanese population. Stroke 40: 1245-1251, 2009.
27. A1/A2 polymor phism interact in the risk of lacunar stroke and midterm survival. Stroke 38: 50-55, 2007.